Although H19, MEG3 and MALAT1 were selected merely as representatives of (g)OS/IFM-related lncRNAs for the pilot study in order to test the hypothesized relevance of this class of molecules as GDM biomarkers, we acknowledge the limitations of using candidates instead of lncRNA profiling. This evidence concerns the gene MEG3 and gestational diabetes.